Online Media Kit
FEATURED STORY
March 16, 2022 | Times LIVE (South Africa)
More HIV prevention options for SA women as vaginal ring approved
The South African Health Products Regulatory Authority (SAHPRA) okayed the use of the monthly dapivirine vaginal ring by adult women. More »
FEATURED STORY
February 26, 2022 | The East African (Kenya)
Young women prefer vaginal ring to daily oral pill for HIV prevention
Given a choice between two HIV prevention products, most adolescent girls and young women who had used both products while participating in the REACH study chose the monthly dapivirine ring. More »
FEATURED STORY
January 26, 2021 | World Health Organization
WHO recommends the dapivirine vaginal ring as a new choice for HIV prevention for women at substantial risk of HIV infection
WHO recommended that the dapivirine vaginal ring, a female-initiated option to reduce the risk of HIV infection, may be offered as an additional prevention choice for women at substantial HIV risk as... More »
Media Highlights
July 28, 2020 | ZTN News (Zimbabwe)
Dapivirine Ring Provides Safe Sex For Women
The ring is inserted into the vagina and lasts for 28 days, providing protection against HIV. However, it does not protect one from sexually transmitted infections and pregnancy. More »
July 28, 2020 | ONU Info
Prévention du VIH : l'ONUSIDA espère que l’anneau vaginal antirétroviral sera mis à disposition des femmes en Afrique subsaharienne
UNAIDS's press statement in French. More »
July 28, 2020 | UNAIDS
UNAIDS is hopeful that a new long-acting HIV prevention option will soon become available for women in sub-Saharan Africa
UNAIDS congratulates IPM on obtaining a positive opinion from the EMA on the dapivirine vaginal ring. The monthly ring adapts a medical technology commonly used as a contraceptive device to deliver... More »
July 28, 2020 | Life4me+ (Germany)
EMA empfiehlt Dapivirin-Vaginalring zum Schutz vor HIV
The EMA recommends approval for women over the age of 18 in combination with other safer sex practices. More »
July 28, 2020 | Deutsche Apotheker Zeitung (DAZ) (Germany)
Dapivirin-Vaginalring zum Schutz vor HIV-1
The CHMP advises that a dapivirine vaginal ring be approved in countries outside the EU. TThe ring is said to have reduced the infection rate by 35 percent in studies. More »